201 related articles for article (PubMed ID: 10077772)
1. [In vitro susceptibilities of clinical isolates of coagulase-negative staphylococci to glycopeptide antibiotics].
Kato D; Hanaki H; Cui L; Oguri T; Hiramatsu K
Jpn J Antibiot; 1998 Dec; 51(12):735-45. PubMed ID: 10077772
[TBL] [Abstract][Full Text] [Related]
2. Comparative analysis and validation of different assays for glycopeptide susceptibility among methicillin-resistant Staphylococcus aureus strains.
Bernard L; Vaudaux P; Rohner P; Huggler E; Armanet M; Pittet D; Lew DP; Schrenzel J
J Microbiol Methods; 2004 May; 57(2):231-9. PubMed ID: 15063063
[TBL] [Abstract][Full Text] [Related]
3. European Glycopeptide Susceptibility Survey of gram-positive bacteria for 1995. European Glycopeptide Resistance Survey Study Group.
Felmingham D; Brown DF; Soussy CJ
Diagn Microbiol Infect Dis; 1998 Aug; 31(4):563-71. PubMed ID: 9764397
[TBL] [Abstract][Full Text] [Related]
4. Antimicrobial susceptibility of coagulase-negative staphylococci and characterization of isolates with reduced susceptibility to glycopeptides.
Del' Alamo L; Cereda RF; Tosin I; Miranda EA; Sader HS
Diagn Microbiol Infect Dis; 1999 Jul; 34(3):185-91. PubMed ID: 10403098
[TBL] [Abstract][Full Text] [Related]
5. [Activity of vancomycin, teicoplanin and linezolid in methicillin resistant coagulase-negative Staphylococci isolates from paediatric blood cultures].
Fajardo Olivares M; Hidalgo Orozco R; Rodríguez Garrido S; Gaona Álvarez C; Sánchez Silos RM; Hernández Rastrollo R; Martínez Tallo E; Cordero Carrasco JL
Rev Esp Quimioter; 2012 Mar; 25(1):25-30. PubMed ID: 22488538
[TBL] [Abstract][Full Text] [Related]
6. Glycopeptide resistance in coagulase-negative staphylococci.
Biavasco F; Vignaroli C; Varaldo PE
Eur J Clin Microbiol Infect Dis; 2000 Jun; 19(6):403-17. PubMed ID: 10947214
[TBL] [Abstract][Full Text] [Related]
7. [Sensitivity to vancomycin and teicoplanin of coagulase-negative staphylococci isolated from clinical specimens].
Młynarczyk G; Młynarczyk A; Luczak M; Jeljaszewicz J
Med Dosw Mikrobiol; 1999; 51(1-2):17-23. PubMed ID: 10865426
[TBL] [Abstract][Full Text] [Related]
8. Investigation of Staphylococcus strains with heterogeneous resistance to glycopeptides in a Turkish university hospital.
Nakipoglu Y; Derbentli S; Cagatay AA; Katranci H
BMC Infect Dis; 2005 May; 5():31. PubMed ID: 15871748
[TBL] [Abstract][Full Text] [Related]
9. [Comparative in vitro activity of glycopeptides against coagulase negative staphylococci isolated in pediatric hospital units].
Bourgeois F; Bingen E; Lambert-Zechovsky N
Pathol Biol (Paris); 1992 Jan; 40(1):36-9. PubMed ID: 1533278
[TBL] [Abstract][Full Text] [Related]
10. Glycopeptide susceptibility profiles of Staphylococcus haemolyticus bloodstream isolates.
Biavasco F; Vignaroli C; Lazzarini R; Varaldo PE
Antimicrob Agents Chemother; 2000 Nov; 44(11):3122-6. PubMed ID: 11036034
[TBL] [Abstract][Full Text] [Related]
11. Changing susceptibilities of coagulase-negative staphylococci to teicoplanin in a teaching hospital.
Sloos JH; van de Klundert JA; Dijkshoorn L; van Boven CP
J Antimicrob Chemother; 1998 Dec; 42(6):787-91. PubMed ID: 10052903
[TBL] [Abstract][Full Text] [Related]
12. Glycopeptide susceptibility profiles of nosocomial multiresistant Staphylococcus haemolyticus isolates.
Tabe Y; Nakamura A; Igari J
J Infect Chemother; 2001 Sep; 7(3):142-7. PubMed ID: 11810575
[TBL] [Abstract][Full Text] [Related]
13. Selection of resistance to glycopeptide antibiotics in staphylococci.
Biavasco F; Giovanetti E; Varaldo PE
J Chemother; 1991 Jan; 3 Suppl 1():166-8. PubMed ID: 12041756
[TBL] [Abstract][Full Text] [Related]
14. Heterogeneous resistance to vancomycin in Staphylococcus epidermidis, Staphylococcus haemolyticus and Staphylococcus warneri clinical strains: characterisation of glycopeptide susceptibility profiles and cell wall thickening.
Nunes AP; Teixeira LM; Iorio NL; Bastos CC; de Sousa Fonseca L; Souto-Padrón T; dos Santos KR
Int J Antimicrob Agents; 2006 Apr; 27(4):307-15. PubMed ID: 16542825
[TBL] [Abstract][Full Text] [Related]
15. Susceptibility of Staphylococcus species and subspecies to teicoplanin.
Bannerman TL; Wadiak DL; Kloos WE
Antimicrob Agents Chemother; 1991 Sep; 35(9):1919-22. PubMed ID: 1835340
[TBL] [Abstract][Full Text] [Related]
16. [Teicoplanin and vancomycin susceptibility in Staphylococcus aureus and coagulase-negative staphylococci].
Caiaffa Filho HH; Lima Mde P; Sinto SI; Andriolo A; Mendes CM
Rev Assoc Med Bras (1992); 1994; 40(2):77-80. PubMed ID: 7820154
[TBL] [Abstract][Full Text] [Related]
17. In vitro activity of teicoplanin and vancomycin against gram-positive bacteria from human clinical and veterinary sources.
Jensen KT; Schønheyder H; Pers C; Thomsen VF
APMIS; 1992 Jun; 100(6):543-52. PubMed ID: 1535201
[TBL] [Abstract][Full Text] [Related]
18. In vitro susceptibility of Staphylococci and Enterococci to vancomycin and teicoplanin.
Guzek A; Korzeniewski K; Nitsch-Osuch A; Rybicki Z; Prokop E
Adv Exp Med Biol; 2013; 788():125-32. PubMed ID: 23835969
[TBL] [Abstract][Full Text] [Related]
19. Heterogeneous resistance to vancomycin and teicoplanin among Staphylococcus spp. isolated from bacteremia.
Nunes AP; Schuenck RP; Bastos CC; Magnanini MM; Long JB; Iorio NL; Santos KR
Braz J Infect Dis; 2007 Jun; 11(3):345-50. PubMed ID: 17684637
[TBL] [Abstract][Full Text] [Related]
20. [In vitro activity of vancomycin and teicoplanin against gram-positive cocci].
Bezian MC; Ribou G; Masquelier B
Pathol Biol (Paris); 1992 May; 40(5):461-5. PubMed ID: 1386667
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
